SCHEMBL1893797

SCHEMBL1893797

Cc1ccc(C(=O)C(=Cc2ccccc2)C(=O)OC(C)(C)C)c(O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
IDO1 P14902 2/20 0.39
TDO2 P48775 2/20 0.39
NFE2L2 Q16236 1/20 0.39
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GPR55 Q9Y2T6 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
PIK3CG P48736 1/20 0.37
NPC1 O15118 1/20 0.36
RECQL P46063 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1893794 1.00 KMT2A (0.46) KMT2AMEN1IDO1TDO2NFE2L2
SCHEMBL1893795 1.00 KMT2A (0.46) KMT2AMEN1IDO1TDO2NFE2L2
SCHEMBL1887493 0.86 MEN1 (0.48) KMT2AMEN1LMNAMAPTNFKB1
SCHEMBL1887498 0.86 MEN1 (0.48) KMT2AMEN1LMNAMAPTNFKB1
SCHEMBL1887496 0.86 MEN1 (0.48) KMT2AMEN1LMNAMAPTNFKB1
SCHEMBL1893667 0.86 ABCG2 (0.53) KMT2AMEN1LMNAMAPTNR1H4
SCHEMBL1893669 0.86 ABCG2 (0.53) KMT2AMEN1LMNAMAPTNR1H4
SCHEMBL1893666 0.86 ABCG2 (0.53) KMT2AMEN1LMNAMAPTNR1H4
SCHEMBL1895083 0.85 MAPT (0.47) KMT2AMEN1LMNAMAPTNFKB1
SCHEMBL1895082 0.85 MAPT (0.47) KMT2AMEN1LMNAMAPTNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110117649-A1 Catalytic enantioselective synthesis of flavanones and chromanones NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-05-19 US disclosed
US-7851640-B2 Catalytic enantioselective synthesis of flavanones and chromanones NORTHWESTERN UNIVERSITY (US) 2010-12-14 US disclosed
US-20090259055-A1 Catalytic enantioselective synthesis of flavanones and chromanones NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259055-A1 Catalytic enantioselective synthesis of flavanones and chromanones RNGTT, CDK20, TBXAS1 KMT2A 2596/4885MEN1 4332/4885IDO1 1521/4885
US-20110117649-A1 Catalytic enantioselective synthesis of flavanones and chromanones RNGTT, CDK20, TBXAS1 KMT2A 2596/4885MEN1 4332/4885IDO1 1521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.